Nishin Bhadkamkar, MD
Department of General Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor (Joint appointment), Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX
Education & Training
Degree-Granting Education
| 2005 | Baylor College of Medicine, Houston, Texas, US, MD |
| 2001 | Rice University, Houston, Texas, US, Economics, BA |
Postgraduate Training
| 2014-2014 | Quality Improvement, Clinical Safety and Effectiveness Program, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2008-2011 | Clinical Fellowship, Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2005-2008 | Clinical Residency, Internal Medicine, Emory University School of Medicine, Atlanta, Georgia |
Board Certifications
| 2011 | Medical Oncology Board Certification |
| 2008 | Internal Medicine |
Experience & Service
Academic Appointments
Associate Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2023
Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2023
Assistant Professor, Department of Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2017
Assistant Professor, Department of General Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2017
Administrative Appointments/Responsibilities
Program Director ad interim, Hematology/Oncology Fellowship Program, Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2024
Associate Program Director, Hematology/Oncology Fellowship Program, Department of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, 2019 - 2020
Director of Education, Hematology/Oncology Fellowship Program, MD Anderson Cancer Center, Houston, TX, 2016 - 2019
Director, Didactic Core Curriculum, Hematology/Oncology Fellowship Program, MD Anderson Cancer Center, Houston, TX, 2016 - 2024
Director of Education, Medical Oncology, Lyndon B. Johnson Hospital, Houston, TX, 2015 - 2020
Director, Medical Oncology Fund of Knowledge Exam, Department of Hematology/Oncology Fellowship Program, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2014 - 2024
Education Course Coordinator, Medical Oncology, Lyndon B. Johnson Hospital, Houston, TX, 2013 - 2015
Other Appointments/Responsibilities
Program Co-Chair, General Oncology Grand Rounds, MD Anderson Cancer Center, Houston, TX, 2018 - 2023
Program Co-Chair, LBJ/MD Anderson Breast Tumor Board, Lyndon B. Johnson Hospital, Houston, TX, 2015 - 2020
Chair, Rectal Cancer Working Group, Lyndon B. Johnson Hospital, Houston, 2014 - 2017
Faculty Interviewer, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2013 - 2024
Faculty Adviser, Master Clinician Track, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2013 - 2020
Pathology Liaison, Medical Oncology, Lyndon B. Johnson Hospital, Houston, TX, 2012 - 2020
Program Chair, LBJ/MD Anderson GI/GU Tumor Board, Lyndon B. Johnson Hospital, Houston, TX, 2011 - 2020
Attending Faculty in Oncology Clinic, Lyndon B. Johnson Hospital, Houston, TX, 2011 - Present
Institutional Committee Activities
Chair, Pharmacy and Therapeutics Committee, 2021 - 2024
Member, Hematology/Medical Oncology Board Review Planning Committee, 2020 - Present
Faculty Leader, Education Committee, Hematology/Oncology Fellowship Program, 2019 - 2022
Vice Chair, Pharmacy and Therapeutics Committee, 2019 - 2021
Member, Faculty Academic Review Committee, 2019 - Present
Chair, Clinical Competency Committee, Hematology/Oncology Fellowship Program, 2017 - 2024
Member, Operational Priority Task Force for Education, 2017 - 2018
Member, Executive Committee, Hematology/Oncology Fellowship Program, 2016 - 2024
Member, Graduate Medical Education Curriculum Subcommittee, 2016 - Present
Member, Steering Committee, Hematology/Oncology Fellowship Program, 2015 - 2024
Member, Pharmacy and Therapeutics Committee, 2013 - 2019
General Oncology Representative, Faculty Senate, 2013 - 2019
Member, Clinical Competency Committee, Hematology/Oncology Fellowship Program, 2013 - 2017
Honors & Awards
| 2022 | MD Anderson Distinguished Educator, MDACC Academy of Health Science Education |
| 2019 | Education Scholars Program, American Society of Clinical Oncology |
| 2018 | Education Scholars Program, American Society of Clinical Oncology |
| 2018 | The Vicente Valero LBJ Clinician Educator of the Year Award, MDACC Hematology/Oncology Fellowship Program |
| 2018 | President's Recognition for Faculty Excellence (Education and Mentorship Advancement), MD Anderson Cancer Center |
| 2017 | The Vicente Valero LBJ Clinician Educator of the Year Award, MDACC Hematology/Oncology Fellowship Program |
| 2017 | Leadership in Education Award, Division of Cancer Medicine, MD Anderson Cancer Center |
| 2017 | Emil J. Freireich Award for Excellence in Education, Department of Clinical Education, MD Anderson Cancer Center |
| 2016 | The Vicente Valero LBJ Clinician Educator of the Year Award, MDACC Hematology/Oncology Fellowship Program |
| 2016 | Teacher of the Year, MDACC Hematology/Oncology Fellowship Program |
| 2015 | Faculty Educator of the Month (July), MD Anderson Cancer Center |
| 2015 | Teacher of the Year, MDACC Hematology/Oncology Fellowship Program |
| 2014 | The Vicente Valero LBJ Clinician Educator of the Year Award, MDACC Hematology/Oncology Fellowship Program |
| 2014 | Teacher of the Year, MDACC Hematology/Oncology Fellowship Program |
| 2013 | The Vicente Valero LBJ Clinician Educator of the Year Award, MDACC Hematology/Oncology Fellowship Program |
| 2013 | Teacher of the Year, MDACC Hematology/Oncology Fellowship Program |
| 2012 | The Vicente Valero LBJ Clinician Educator of the Year Award, MDACC Hematology/Oncology Fellowship Program |
| 2011 | Educational Grant, Patricia Hodson Endowment Fund |
| 2010 | AACR/ASCO Workshop: Methods in Clinical Cancer Research |
| 2009 | Educational Grant, International Society of Gastrointestinal Oncology |
| 2003 | Honors in Basic Sciences, Baylor College of Medicine |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Giuliani ME, Bhadkamkar NA, Giannopoulos E, Lubner S, Tseng J, Tibbits M, Von Roenn JH. Advancing the clinician educator career pathway in oncology. JCO Oncol Pract 19(5):e630-e638, 2023. e-Pub 2022. PMID: 36534924.
- Singhi EK, Dupuis MM, Ross JA, Rieber AG, Bhadkamkar NA. Medical Hematology/Oncology Fellows' Perceptions of Online Medical Education During the COVID-19 Pandemic. J Cancer Educ 35(5):1034-1040, 2020. PMID: 32888144.
- Wang XS, Shi Q, Bhadkamkar NA, Cleeland CS, Garcia-Gonzalez A, Aguilar JR, Heijnen C, Eng C. Minocycline for Symptom Reduction During Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial. J Pain Symptom Manage 58(4):662-671, 2019. e-Pub 2019. PMID: 31254639.
- Parkes A, Nusrat M, Di Tomasso PM, Davis L, Ogbonnaya S, Iwuorie M, Patel S, Abraham TG, Mack R, Bhadkamkar NA, Ma H, Nazario LA, Ramondetta L, Rosenstock A, Rieber AG. Successful Implementation of a Multidisciplinary Chemotherapy Efficiency Initiative at a Community Hospital. J Oncol Pract 15(6):JOP1800541, 2019. e-Pub 2019. PMID: 30990730.
- Ramsey SD, Unger JM, Baker LH, Little RF, Loomba R, Hwang JP, Chugh R, Konerman MA, Arnold K, Menter AR, Thomas E, Michels RM, Jorgensen CW, Burton GV, Bhadkamkar NA, Hershman DL. The Prevalence of Hepatitis B, Hepatitis C, and HIV Infection among Newly Diagnosed Cancer Patients Treated in Academic and Community Oncology Practices: SWOG S1204. JAMA Oncol 5(4):497-505, 2019. e-Pub 2019. PMID: 30653226.
- Unger JM, Hershman DL, Arnold KB, Loomba R, Chugh R, Hwang JP, O'Rourke MA, Bhadkamkar NA, Wang LX, Siegel AB, Cooley TP, Berenberg JL, Bridges BB, Ramsey SD. Stepwise Development of a Cancer Care Delivery Research Study to Evaluate the Prevalence of Virus Infections in Cancer Patients: SWOG S1204. Future Oncol 12(10):1219-31, 2016. e-Pub 2016. PMID: 26952901.
- Hoffmann MS, Leslie LA, Jacobs RW, Millas S, Surabhi V, Mok H, Jhaveri P, Kott MM, Jackson L, Rieber A, Bhadkamkar NA. Reducing the time from diagnosis to treatment of patients with stage II/III rectal cancer at a large public hospital. J Oncol Pract 12(2):e257-62, 2016. PMID: 26869658.
- Sahin IH, Kazmi SM, Yorio JT, Bhadkamkar NA, Kee BK, Garrett CR. Rare Though Not Mutually Exclusive: A Report of Three Cases of Concomitant KRAS and BRAF Mutation and a Review of the Literature. J Cancer 4(4):320-2, 2013. e-Pub 2013. PMID: 23569465.
- Garrett CR, George B, Viswanathan C, Bhadkamkar NA, Wen S, Baladandayuthapani V, You YN, Kopetz ES, Overman MJ, Kee BK, Eng C. Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary. Clin Colorectal Cancer 11(3):191-4, 2012. e-Pub 2012. PMID: 22280844.
- Garrett CR, Hassabo HM, Bhadkamkar NA, Wen S, Baladandayuthapani V, Kee BK, Eng C, Hassan MM. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer. Br J Cancer 106(8):1374-8, 2012. e-Pub 2012. PMID: 22421948.
- Mian BM, Bhadkamkar N, Slaton JW, Pisters PW, Daliani D, Swanson DA, Pisters LL. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol 167(1):65-70, 2002. PMID: 11743277.
Invited Articles
- Rieber AG, McQuade JL, Bhadkamkar NA, Lopez G, Lee RT. Commentary on "Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis". Breast Diseases: A Year Book Quarterly 25(4):321-2, 2015. PMID: None.
- Yorio JT, Bhadkamkar NA, Kee BK, Garrett CR. A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas. Int J Surg Oncol 2012(None):863034, 2012. e-Pub 2012. PMID: 22666572.
Other Articles
- Hutchings K, Al Zaki A, Bhadkamkar N, Willis J Symptomatic pseudoprogression in metastatic colorectal cancer. BMJ Case Rep 17(6), 2024. PMID: 38871645.
- Shah MA, Kennedy EB, Alarcon-Rozas AE, Alcindor T, Bartley AN, Malowany AB, Bhadkamkar NA, Deighton DC, Janjigian Y, Karippot A, Khan U, King DA, Klute K, Lacy J, Lee JJ, Mehta R, Mukherjee S, Nagarajan A, Park H, Saeed A, Semrad TJ, Shitara K, Smyth E, Uboha NV, Vincelli M, Wainberg Z, Rajdev L Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline. J Clin Oncol 41(7):1470-1491, 2023. PMID: 36603169.
- Wo JY, Anker CJ, Ashman JB, Bhadkamkar NA, Bradfield L, Chang DT, Dorth J, Garcia-Aguilar J, Goff D, Jacqmin D, Kelly P, Newman NB, Olsen J, Raldow AC, Ruiz-Garcia E, Stitzenberg KB, Thomas CR, Wu QJ, Das P Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol 11(1):13-25, 2021. PMID: 33097436.
- Bhadkamkar NA How I Became a General Oncologist and Training Program Director. ASCO Connection, 2019. PMID: None.
Abstracts
- Bhadkamkar NA, Sahin IH, Shen Y, et al. Outcomes in patients (pts) with colorectal cancer (CRC) treated with oxaliplatin-based chemotherapy (OC) following prior oxaliplatin exposure. J Clin Oncol 31(4S):500, 2013. PMID: None.
Book Chapters
- Uemura M, Krishnan S, Kaseb AO, Bhadkamkar NA, Javle MM, Avritscher RA. Hepatocellular Carcinoma. In: The MD Anderson Manual of Medical Oncology. 3rd ed. McGraw-Hill, 2016.
- Bhadkamkar NA, Crane CH, Rodriguez-Bigas MA, Kopetz S, Eng C. Colorectal Cancer. In: The MD Anderson Manual of Medical Oncology. 2nd ed. McGraw-Hill, 2011.
- Bhadkamkar NA, Javle MM, Avritscher R, Krishnan S, Kaseb AO. Hepatobiliary Malignancies. In: The MD Anderson Manual of Medical Oncology. 2nd ed. McGraw-Hill, 2011.
- Bhadkamkar NA, Khuri FR. Retinoids and rexinoids in lung cancer. In: Lung Cancer. 3rd ed. Blackwell, 2007.
Grant & Contract Support
| Title: | Genome-Wide Association Study in Hepatocellular Carcinoma |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Title: | Reducing Chemotherapy-Induced Neuropathy in CRC Patients Using Minocycline |
| Funding Source: | American Cancer Society (ACS) |
| Role: | Co-PI |
| Title: | Correcting Disparities in Pancreatic Cancer Genomics Research |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Title: | Supporting and Enhancing Caregiving for Individuals with Colorectal Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Title: | Prevention of Hepatitis C Virus-Associated Second Primary Malignancies |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-Program Leader |
| Title: | The Hepatocellular Carcinoma Project |
| Funding Source: | MDACC Moon Shots Program |
| Role: | Co-I |
| Title: | Improving Coordination of Care and Education for Medically Underserved Patients Diagnosed with Colorectal Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| Title: | Novel Point-of-Care Tool to Predict Response to Sorafenib in Hepatocellular Carcinoma |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| Title: | A Novel Tool for Predicting Response to Systemic Therapy in Patients with Hepatocellular Carcinoma |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Title: | Improving Patient-Centered Outcomes in High-Risk Medically Disadvantaged Cancer Patients |
| Funding Source: | PCORI |
| Role: | Co-I |
Patient Reviews
CV information above last modified October 15, 2024